Anti-Apolipoprotein CIII antibody [EPR1371(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal Apolipoprotein CIII antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
Apolipoprotein C-III, Apo-CIII, ApoC-III, Apolipoprotein C3, APOC3
- WB
Unknown
Western blot - Anti-Apolipoprotein CIII antibody [EPR1371(2)] (AB108205)
All lanes:
Western blot - Anti-Apolipoprotein CIII antibody [EPR1371(2)] (ab108205) at 1/1000 dilution
Lane 1:
Human plasma at 10 µg
Lane 2:
HDL recombinant protein at 10 µg
Predicted band size: 11 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apolipoprotein CIII antibody [EPR1371(2)] (AB108205)
ab108205 at 1/250 dilution staining Apolipoprotein CIII in paraffin-embedded Human liver tissue by immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Related conjugates and formulations (1)
-
Anti-Apolipoprotein CIII antibody [EPR1371(2)] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Apolipoprotein CIII plays a pivotal role in lipid and lipoprotein metabolism. It is not part of a large protein complex but interacts with lipoproteins as a modulatory protein. Apo C-III affects triglyceride metabolism by delaying the clearance of VLDL and enhancing hepatic triglyceride secretion. Additionally it modulates the uptake of lipoprotein remnants by liver receptors thereby influencing the plasma levels of triglycerides and cholesterol.
Pathways
Apolipoprotein CIII is involved in the regulation of lipid metabolic pathways. It plays a role in the lipoprotein assembly pathway and the triglyceride biosynthetic process. This protein impacts the interaction between lipoprotein lipase and its substrates hindering enzyme activity which leads to elevated plasma triglyceride levels. It relates closely to other apolipoproteins such as apolipoprotein E which also participates in lipid transport and metabolism although with distinct functions and regulatory mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:32986 PubMed41006587
2025
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 8: PubMed39578076
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e22084 PubMed38058614
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proteomics. Clinical applications 14:e1900062 PubMed31532894
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com